Benjamin Chastek

1.2k total citations
60 papers, 910 citations indexed

About

Benjamin Chastek is a scholar working on Epidemiology, Rheumatology and Immunology. According to data from OpenAlex, Benjamin Chastek has authored 60 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Rheumatology and 13 papers in Immunology. Recurrent topics in Benjamin Chastek's work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). Benjamin Chastek is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Microscopic Colitis (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). Benjamin Chastek collaborates with scholars based in United States, United Kingdom and India. Benjamin Chastek's co-authors include April Teitelbaum, Lee N. Newcomer, Carly J. Paoli, Carolyn Harley, Joel Kallich, Maria Lopez-Bresnahan, MerriKay Oleen-Burkey, Jeffrey R. Curtis, Oluwakayode Adejoro and Jessica A. Walsh and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Benjamin Chastek

56 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Chastek United States 17 219 187 179 168 148 60 910
Julia Snowball United Kingdom 18 159 0.7× 603 3.2× 172 1.0× 132 0.8× 277 1.9× 45 1.2k
Jakub Závada Czechia 19 481 2.2× 73 0.4× 306 1.7× 45 0.3× 107 0.7× 59 1.2k
Arti Parikh‐Patel United States 21 210 1.0× 621 3.3× 78 0.4× 119 0.7× 272 1.8× 49 1.6k
Silvia Dehler Switzerland 19 380 1.7× 472 2.5× 170 0.9× 111 0.7× 107 0.7× 43 1.4k
Adela Mattiazzi United States 21 141 0.6× 153 0.8× 179 1.0× 245 1.5× 151 1.0× 56 1.8k
Cyrille Huchon France 24 111 0.5× 270 1.4× 109 0.6× 477 2.8× 89 0.6× 161 2.5k
A W Craft United Kingdom 19 108 0.5× 207 1.1× 72 0.4× 245 1.5× 391 2.6× 48 1.3k
Ana P. Lacerda United States 14 451 2.1× 170 0.9× 427 2.4× 103 0.6× 40 0.3× 66 1.4k
Emily Ko United States 24 59 0.3× 669 3.6× 179 1.0× 196 1.2× 169 1.1× 186 2.1k
Tanya Pankhurst United Kingdom 14 96 0.4× 58 0.3× 100 0.6× 41 0.2× 200 1.4× 33 697

Countries citing papers authored by Benjamin Chastek

Since Specialization
Citations

This map shows the geographic impact of Benjamin Chastek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Chastek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Chastek more than expected).

Fields of papers citing papers by Benjamin Chastek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Chastek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Chastek. The network helps show where Benjamin Chastek may publish in the future.

Co-authorship network of co-authors of Benjamin Chastek

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Chastek. A scholar is included among the top collaborators of Benjamin Chastek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Chastek. Benjamin Chastek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
McGovern, Ian, Benjamin Chastek, Tim Bancroft, et al.. (2024). Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017–2020 influenza seasons. International Journal of Infectious Diseases. 146. 107160–107160. 1 indexed citations
3.
4.
5.
Cleveland, Noa Krugliak, Sabyasachi Ghosh, Benjamin Chastek, et al.. (2024). Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY. BMC Gastroenterology. 24(1). 314–314. 2 indexed citations
6.
Chastek, Benjamin, et al.. (2024). Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis. Advances in Therapy. 41(5). 2086–2097. 1 indexed citations
7.
Cleveland, Noa Krugliak, Sabyasachi Ghosh, Benjamin Chastek, et al.. (2023). Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY. Inflammatory Bowel Diseases. 30(10). 1776–1787. 9 indexed citations
8.
Singer, David, et al.. (2023). Impact of chronic fibrosing interstitial lung disease on healthcare use: association between fvc decline and inpatient hospitalization. BMC Pulmonary Medicine. 23(1). 337–337. 3 indexed citations
9.
10.
Blank, Stephanie V., et al.. (2022). Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer. Advances in Therapy. 39(6). 2544–2561. 3 indexed citations
11.
Bell, Christopher F., et al.. (2021). Healthcare Resource Utilization and Costs over 5 Years for a Systemic Lupus Erythematosus (SLE) Cohort Newly Diagnosed with Lupus Nephritis: Evidence from a US Administrative Claims Database. Journal of the American Society of Nephrology. 32(10S). 454–454. 1 indexed citations
12.
Buikema, Ami, Misti L. Paudel, Jonathan Johnson, et al.. (2021). Racial and ethnic disparity in clinical outcomes among patients with confirmed COVID-19 infection in a large US electronic health record database. EClinicalMedicine. 39. 101075–101075. 29 indexed citations
13.
Chastek, Benjamin, et al.. (2018). SAT0177 Real-world interruptions in janus kinase inhibitor therapy observed among biologic-naÏve and biologic-experienced rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 77. 949–950. 1 indexed citations
14.
Chastek, Benjamin, Chieh-I Chen, Clare Proudfoot, et al.. (2017). Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA. Advances in Therapy. 34(11). 2422–2435. 33 indexed citations
15.
16.
Chastek, Benjamin, Mahesh Kulakodlu, Satish Valluri, & Brian Seal. (2012). CN4 Total Health Care Costs for Colorectal Cancer Patients Following Metastatic Diagnosis. Value in Health. 15(4). A1–A1. 1 indexed citations
17.
Chastek, Benjamin, Kathleen M. Fox, Crystal Watson, & Shravanthi R. Gandra. (2012). Etanercept and Adalimumab Treatment Patterns in Psoriatic Arthritis Patients Enrolled in a Commercial Health Plan. Advances in Therapy. 29(8). 691–697. 22 indexed citations
18.
Bonafede, R. Peter, Douglas C. Pearson, Benjamin Chastek, et al.. (2011). CO1 COMPARATIVE EFFECTIVENESS ANALYSIS OF TNF BLOCKERS IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN A REAL-WORLD SETTING. Value in Health. 14(3). A1–A2. 4 indexed citations
19.
Amonkar, Mayur M., et al.. (2011). Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population. Journal of Medical Economics. 14(4). 421–432. 20 indexed citations
20.
Darkow, Theodore, Benjamin Chastek, Hemal Shah, & Amy Phillips. (2008). Health Care Costs Among Individuals With Chronic Obstructive Pulmonary Disease Within Several Large, Multi-State Employers. Journal of Occupational and Environmental Medicine. 50(10). 1130–1138. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Snowball Breakdown of academic impact, for papers by Jakub Závada Breakdown of academic impact, for papers by Arti Parikh‐Patel Breakdown of academic impact, for papers by Silvia Dehler Breakdown of academic impact, for papers by Adela Mattiazzi Breakdown of academic impact, for papers by Cyrille Huchon Breakdown of academic impact, for papers by A W Craft Breakdown of academic impact, for papers by Ana P. Lacerda Breakdown of academic impact, for papers by Emily Ko Breakdown of academic impact, for papers by Tanya Pankhurst
Rankless by CCL
2026